Moreover, recent studies revealed increased FAP expression in CAFs of PCa that correlate with PCa prognosis [16, 37, 38], and FAP targeting ligands are being evaluated as therapeutic carriers in multiple cancer patient trials [39, 40]. Here, FAP is linked to posterior cortical atrophy.